These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35247197)
21. Expression analysis of circulating miR-22, miR-122, miR-217 and miR-367 as promising biomarkers of acute lymphoblastic leukemia. Hosseinpour-Soleimani F; Khamisipour G; Derakhshan Z; Ahmadi B Mol Biol Rep; 2023 Jan; 50(1):255-265. PubMed ID: 36327023 [TBL] [Abstract][Full Text] [Related]
22. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia. Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096 [TBL] [Abstract][Full Text] [Related]
23. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Wang F; Wang XS; Yang GH; Zhai PF; Xiao Z; Xia LY; Chen LR; Wang Y; Wang XZ; Bi LX; Liu N; Yu Y; Gao D; Huang BT; Wang J; Zhou DB; Gong JN; Zhao HL; Bi XH; Yu J; Zhang JW Mol Biol Rep; 2012 Mar; 39(3):2713-22. PubMed ID: 21678057 [TBL] [Abstract][Full Text] [Related]
24. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia. Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222 [TBL] [Abstract][Full Text] [Related]
25. [Expression and Clinical Significance of Serum MiR-370 and MiR-203 in Patients with Acute Myeloid Leukemia]. Ye LH; Ma X; Xu SC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):445-449. PubMed ID: 33812413 [TBL] [Abstract][Full Text] [Related]
26. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
27. Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential. Yang J; Yuan Y; Yang X; Hong Z; Yang L Pathol Res Pract; 2017 Sep; 213(9):1166-1172. PubMed ID: 28822593 [TBL] [Abstract][Full Text] [Related]
28. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia. Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877 [TBL] [Abstract][Full Text] [Related]
30. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia. Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855 [TBL] [Abstract][Full Text] [Related]
32. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of miR-96 in patients with acute myeloid leukemia. Zhao J; Lu Q; Zhu J; Fu J; Chen YX Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958 [TBL] [Abstract][Full Text] [Related]
34. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia. Wang Z; Hong Z; Gao F; Feng W Mol Cell Biochem; 2013 Nov; 383(1-2):59-65. PubMed ID: 23864342 [TBL] [Abstract][Full Text] [Related]
35. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia]. Yuan DM; Wu SY; Huang SL; Jiang WC; Ke YB Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1252-1258. PubMed ID: 28910942 [No Abstract] [Full Text] [Related]
36. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia. Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic Value of miR-34a in Bone Marrow Mononuclear Cells of Acute Myeloid Leukemia Patients. Liu X; Li H Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162890 [TBL] [Abstract][Full Text] [Related]
38. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia. Valiollahi E; Ribera JM; Genescà E; Behravan J Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia. Guo Y Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]